Mark C. Warburton
Direttore/Membro del Consiglio presso Apex Molecular Ltd.
Profilo
Mark C.
Warburton is a Non-Executive Director at Apex Molecular Ltd.
He was a Non-Executive Director at LSL Property Services Plc from 2006 to 2009.
He was also the COO, Secretary, Legal Counsel & IR Contact at Cyprotex Ltd.
from 2012 to 2017.
Additionally, he worked at Addleshaw Booth & Co. from 2004 to 2007.
Posizioni attive di Mark C. Warburton
| Società | Posizione | Inizio |
|---|---|---|
Apex Molecular Ltd.
 Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Mark C. Warburton
| Società | Posizione | Fine |
|---|---|---|
| CYPROTEX PLC | Direttore operativo | 30/06/2017 |
| LSL PROPERTY SERVICES PLC | Direttore/Membro del Consiglio | 01/06/2009 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LSL PROPERTY SERVICES PLC | Finance |
| Aziende private | 2 |
|---|---|
Cyprotex Ltd.
 Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Apex Molecular Ltd.
Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Mark C. Warburton
